AIDS Alert Archives – June 1, 2011
June 1, 2011
View Issues
-
Research into elite suppressors offers clues to new treatments
Investigators studying "elite suppressors," this unique group of HIV-infected individuals who can ward off illness from HIV for years or even decades, have found clues that might lead to powerful new treatments. -
Trying to solve mystery of CD8 T cells and HIV
HIV research increasingly points to a connection between CD8 T cells and suppressed virus, but precisely how this works remains a mystery. -
Defective virus may explain rare couple
A husband and wife HIV transmission pair offer researchers a rare look at what happens when a long-term nonprogressor is compared over time with an elite suppressor. -
Elite suppressor on chemo? No problem
Elite suppressors are that 1% or fewer of HIV patients who do not develop signs of disease progression despite living for years without treatment. -
'Compelling evidence' spurs release of data
Men and women infected with HIV dramtically reduced the risk of transmitting the virus to their sexual partners through initiation of oral antiretroviral therapy (ART), according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network (HPTN). -
HIV researchers fight rumors, misconceptions
International HIV vaccine trials underway in resource-poor settings provide good examples of how clinical research (CR) can be done in both ethical and culturally-sensitive ways despite a wide variety of obstacles. -
Informed consent or too much info?
Can the informed consent process actually provide too much information? That's the contention of HIV researcher Susan Allen, MD, MPH, who points to a recent study she tried to conduct in Zambia of participants' knowledge about contraceptive options. -
FDA Notifications
The Food and Drug Administration is proposing to amend its regulations to expand the scope of clinical investigator disqualification.